MARC Record from harvard_bibliographic_metadata

LEADER: 02992nam a2200457Ii 4500
001 014271781-9
005 20150120172040.0
008 141110s2015 gw a sb ||01 0|eng d
020 $a9783319097824
020 $a9783319097824
020 $a9783319097817
024 7 $a10.1007/978-3-319-09782-4$2doi
035 $a(Springer)9783319097824
040 $aSpringer
050 4 $aQR46
072 7 $aMMFM$2bicssc
072 7 $aMED052000$2bisacsh
082 04 $a616.9041$223
100 1 $aDonelli, Gianfranco.$eeditor.
245 10 $aBiofilm-based Healthcare-associated Infections volume II /$cedited by Gianfranco Donelli.
264 1 $aCham :$bSpringer International Publishing :$bImprint: Springer,$c[2015]
300 $aviii, 195 pages :$bcolor illustrations ;$c27 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
490 1 $aAdvances in Experimental Medicine and Biology,$x0065-2598 ;$vvolume 831
504 $aIncludes bibliographical references and index.
505 0 $aPersister cells in biofilm associated infections -- Fungal biofilms in human disease -- Biofilm-Infected Pressure Ulcers: Current Knowledge and Emerging Treatment Strategies -- Microbial biofilms and adverse reactions to gel fillers used in cosmetic surgery -- Role of biofilms in breast implant associated infections and capsular contracture -- Innovative strategies for combating biofilm-based infections -- Antimicrobial polymers for anti-biofilm medical devices: state of art and perspectives -- Antimicrobial Photodynamic Therapy for Treatment of Biofilm-based Infections -- Anti-Biofilm Agents in Control of Device-Related Infections -- Lipid- and polymer-based drug delivery carriers for eradicating microbial biofilms causing medical device-related infections.
520 $aThe aim of this book is to provide readers with a wide overview of the main healthcare-associated infections caused by bacteria and fungi able to grow as biofilm. The recently acquired knowledge on the pivotal role played by biofilm-growing microorganisms in healthcare-related infections has given a new dynamic to detection, prevention and treatment of these infections in patients admitted to both acute care hospitals and long-term care facilities. Clinicians, hygienists and microbiologists will be updated by leading scientists on the state-of-art of biofilm-based infections and on the most innovative strategies for prevention and treatment of these infections, often caused by emerging multidrug-resistant biofilm-growing microorganisms.
650 0 $aMedicine.
650 0 $aMicrobiology.
650 0 $aEmerging infectious diseases.
650 0 $aBacteriology.
650 12 $aBiofilms
650 12 $aInfection$xtherapy
650 22 $aAnti-Infective Agents
650 22 $aHealth Facilities
650 22 $aDisinfection
830 0 $aAdvances in Experimental Medicine and Biology,$x0065-2598 ;$vv. 831.
988 $a20150106
906 $0VEN